Freenome
Overview
Freenome is a private biotech company that is focused on developing blood tests to detect cancer early and make screening accessible for everyone. The company is setting a new pace for early cancer detection by combining the latest in science and artificial intelligence, with the ease of a standard blood draw. Detecting cancer early can make a world of difference, and Freenome is committed to making this a reality.
Features
| Feature | Description |
|---|
| Multiomics technology | Uses multiple types of data to detect cancer in its earliest stages |
| Intelligent screening platform | Combines science and artificial intelligence for early cancer detection |
| Rigorous clinical program | Drives discovery, development, and validation of early cancer detection tests |
Pricing
| Plan | Price | Features |
|---|
| Not available | Not available | Not available |
Pros & Cons
| Pros | Cons |
|---|
| Early cancer detection | Limited information on pricing and availability |
| Accessible screening | Not available for all types of cancer |
Use Cases
- Early cancer detection and screening
- Accessible screening for everyone
- Combining science and artificial intelligence for better detection
